Faculty Publications
As of August 2017, this database is no longer being updated. For the most current publications from the faculty, students, and staff of Touro University, please check our institutional repository, Touro Scholar, and email any questions or publication submissions to touro.scholar@touro.edu.
Total number of publications: 7,082
Enter a faculty name:
or browse faculty by school:
Administrative Offices
Graduate Schools
Health Sciences
Lander Colleges
Law Center
New York School of Career and Applied Studies (NYSCAS)
Touro University System
New York Medical College (NYMC)
Touro University California
Touro University Nevada
Espana Schmidt, C., Pastori, L., Pekler, G., Visco, F., & Mushiyev, S. (2015). Early use of beta blockers in patients with cocaine associated chest pain. IJC Heart and Vasculature, 8, 167-169. doi:10.1016/j.ijcha.2015.06.001
Ezigbo, C., Sy, A. M., Popescu-Martinez, A., Boma, N., & Bergasa, N. V. (2014). Hepatocellular carcinoma in a patient with chronic lymphocytic leukaemia involving the liver. BMJ Case Reports, 2014, bcr2014205634. doi:10.1136/bcr-2014-205634
Feder, H. M., Wormser, G. P., & Cushman, D. A. (2016). A Lyme disease "selfie". Consultant, 56(6), 524-526.
Ferrick, A. M., Tian, D., Vudathaneni, V., Shevchuk, O. L., Ferrick, N. J., & Frishman, W. (2016). Wearable cardioverter defibrillators. Cardiology in Review, 24(6), 282-287. doi:10.1097/CRD.0000000000000120
Fine, A. B., Sweeney, J. D., Nixon, C. P., & Knoll, B. M. (2016). Transfusion-transmitted anaplasmosis from a leukoreduced platelet pool. Transfusion, 56(3), 699-704. doi:10.1111/trf.13392
Forouzanfar, M. H., Afshin, A., Alexander, L. T., Anderson, H. R., Bhutta, Z. A., Biryukov, S., . . . Khera, S. (2016). Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: A systematic analysis for the Global Burden of Disease Study 2015. Lancet, 388(10053), 1659-1724. doi:10.1016/S0140-6736(16)31679-8
Francis, M. D., Julian, K. A., Wininger, D. A., Drake, S., Bollman, K., Nabors, C., . . . Francis, M. L. (2016). Continuity clinic model and diabetic outcomes in internal medicine residencies: Findings of the Educational Innovations Project Ambulatory Collaborative. Journal of Graduate Medical Education, 8(1), 27-32. doi:10.4300/JGME-D-15-00073.1
Francis, M. D., Wieland, M. L., Drake, S., Gwisdalla, K. L., Julian, K. A., Nabors, C. . . . Francis, M. L. (2015). Clinic design and continuity in internal medicine resident clinics: Findings of the educational innovations project ambulatory collaborative. Journal of Graduate Medical Education, 7(1), 36-41. doi:10.4300/JGME-D-14-00358.1
Franz, C. A., & Frishman, W. H. (2016). Marijuana use and cardiovascular disease. Cardiology in Review, 24(4), 158-162. doi:10.1097/CRD.0000000000000103
Friedlander, S. L., Tichenor, W. S., & Skoner, D. P. (2013). Risk of adverse effects, misdiagnosis, and suboptimal patient care with the use of over-the-counter triamcinolone. Annals of Allergy Asthma & Immunology, 111(5), 319-322. doi:10.1016/j.anai.2013.09.013
Frishman, W. H. (2013). Cardiac disease. In P. Boyle, P. Boffetta, A. B. Lowenfels, H. Burns, O. Brawley, W. Zatonski, & J. Rehm (Eds.), Alcohol: Science, policy, and public health (pp. 249-255). Oxford, England: Oxford University Press.
Frishman, W. H. (2013). β-Adrenergic blockade in cardiovascular disease. Journal of Cardiovascular Pharmacology and Therapeutics, 18(4), 310-319. doi:10.1177/1074248413484986
Frishman, W. H. (2015). Can clinicians improve on the effectiveness of statins with additional lipid-lowering therapies? The American Journal of Medicine, 128(11), 1160-1161. doi:10.1016/j.amjmed.2015.06.027
Frishman, W. H. (2015). Is the stethoscope becoming an outdated diagnostic tool? The American Journal of Medicine, 128(7), 668-669. doi:10.1016/j.amjmed.2015.01.042
Frishman, W. H. (2015). Pharmacists in primary care. The American Journal of Medicine, 128(5), 443-444. doi:10.1016/j.amjmed.2014.11.021
Frishman, W. H. (2016). Beta-adrenergic receptor blockers in hypertension: Alive and well. Progress in Cardiovascular Diseases, 59(3), 247-252. doi:10.1016/j.pcad.2016.10.005
Frishman, W. H. (2016). Reflections on the Physicians Payment Sunshine Act. The American Journal of Medicine, 129(1), 3-4. doi:10.1016/j.amjmed.2015.08.001
Frishman, W. H. (2016). The reply. The American Journal of Medicine, 129(9), e203. doi:10.1016/j.amjmed.2016.02.051
Frishman, W. H., & Alpert, J. S. (2013). Reducing hospital readmissions for cardiovascular disease: Is it feasible? American Journal of Medicine, 126(9), 753-754. doi:10.1016/j.amjmed.2013.02.027
Frishman, W. H., & Aronow, W. S. (2013). Systemic hypertension in the elderly. In W. S. Aronow, J. L. Fleg, & M. W. Rich (Eds.), Tresch and Aronow's cardiovascular disease in the elderly (5th ed., pp. 104-120). Boca Raton, FL: CRC Press.
Frishman, W. H., & Glicklich, D. (2014). The role of nonpharmacologic device interventions in the management of drug-resistant hypertension. Current Atherosclerosis Reports, 16(5), 405. doi:10.1007/s11883-014-0405-5
Frishman, W. H., Aronow, W. S., & Cheng-Lai, A. (2013). Cardiovascular drug therapy in the elderly. In W. S. Aronow, J. L. Fleg, & M. W. Rich (Eds.), Tresch and Aronow's cardiovascular disease in the elderly (5th ed., pp. 67-103). Boca Raton, FL: CRC Press.
Frishman, W. H., Nabors, C., & Peterson, S. J. (2013). Faculty supervision of the house staff handoff process: The time has come. American Journal of Medicine, 126(1), e1-e2. doi:10.1016/j.amjmed.2012.07.014
Frishman, W. H., Zimmerman, F. H., & Lerner, R. G. (2013). Vascular and heart diseases in the incumbent presidents and vice presidents of the United States of America: A medical-historical perspective. Cardiology in Review, 21(1), 1-8. doi:10.1097/CRD.0b013e31827303b5
Furqan, M., Akinleye, A., Mukhi, N., Mittal, V., Chen, Y., & Liu, D. (2013). STAT inhibitors for cancer therapy. Journal of Hematology & Oncology, 6 [Article 90]. doi:10.1186/1756-8722-6-90
